Metformin |
62.5 μM |
24 hours |
human |
HepG2 cells |
Assay of Cellular ATP Content |
Negative |
p < 0.001 |
15 |
Metformin |
62.5 μM |
24 hours |
human |
HepG2 cells |
Assay of Cellular ATP Content |
Negative |
p < 0.001 |
15 |
buformin |
62.5 μM |
24 hours |
human |
HepG2 cells |
Assay of Cellular ATP Content |
Positive |
p < 0.001 |
15 |
buformin |
62.5 μM |
24 hours |
human |
HepG2 cells |
Assay of Cellular ATP Content |
Positive |
p < 0.001 |
15 |
Phenformin |
62.5 μM |
24 hours |
human |
HepG2 cells |
Assay of Cellular ATP Content |
Positive |
p < 0.001 |
15 |
Phenformin |
62.5 μM |
24 hours |
human |
HepG2 cells |
Assay of Cellular ATP Content |
Positive |
p < 0.001 |
15 |
Metformin |
657 μM |
24 hours |
human |
hepatocytes |
Assay of Cellular ATP Content |
Positive |
IC50 |
15 |
buformin |
26.1 μM |
24 hours |
human |
hepatocytes |
Assay of Cellular ATP Content |
Positive |
IC50 |
15 |
Phenformin |
11.7 μM |
24 hours |
human |
hepatocytes |
Assay of Cellular ATP Content |
Positive |
IC50 |
15 |
Metformin |
1430 μM |
24 hours |
human |
HepG2 cells |
Assay of Cellular ATP Content |
Positive |
IC50 |
15 |
buformin |
43.7 μM |
24 hours |
human |
HepG2 cells |
Assay of Cellular ATP Content |
Positive |
IC50 |
15 |
Phenformin |
12.9 μM |
24 hours |
human |
HepG2 cells |
Assay of Cellular ATP Content |
Positive |
IC50 |
15 |
Metformin |
> 2000 μM |
24 hours |
human |
HepG2 cells |
Assay of Cellular ATP Content |
Positive |
IC50 |
15 |
buformin |
> 500 μM |
24 hours |
human |
HepG2 cells |
Assay of Cellular ATP Content |
Positive |
IC50 |
15 |
Phenformin |
> 500 μM |
24 hours |
human |
HepG2 cells |
Assay of Cellular ATP Content |
Positive |
IC50 |
15 |
Diclofenac |
250 μmol/L |
24 hours |
rat |
hepatocytes |
Assay of Cellular ATP contents; Assay of LDH leakage |
Positive |
p < 0.01 |
6 |
Diclofenac |
500 μmol/L |
24 hours |
rat |
hepatocytes |
Assay of Cellular ATP contents; Assay of LDH leakage |
Positive |
p < 0.01 |
6 |